- Demographic characteristics of the pregnant women in the study.
| Variables | Total | Disease severity | P-values | |
|---|---|---|---|---|
| Mild-moderate | Severe-critical | |||
| Length of stay in ICU (days), mean±SD (min-max) | 9.2±8.5 (1-26) | 2.0±1.4 (1-3) | 11.0±8.6 (3-26) | 0.064 |
| Having COVID-19 before pregnancy | 4 (1.4) | 4 (1.4) | 0 (0.0) | 1.000 |
| Vaccinated | 4 (1.4) | 4 (1.4) | 0 (0.0) | 1.000 |
| Which vaccine? | ||||
| Two doses of SNVC | 2 (50.0) | 2 (50.0) | - | |
| Two doses of BTC | 2 (50.0) | 2 (50.0) | ||
| In which trimester? | ||||
| First trimester | 66 (22.7) | 65 (23.0) | 1 (11.1) | 0.013 |
| Second trimester | 100 (34.4) | 100 (35.5) | 0 (0.0) | |
| Third trimester | 125 (43.0) | 117 (41.5) | 8 (88.9) | |
| Disease severity | ||||
| Mild | 245 (84.2) | 245 (86.9) | 0 (0.0) | - |
| Moderate | 37 (12.7) | 37 (13.1) | 0 (0.0) | |
| Severe | 3 (1.0) | 0 (0.0) | 3 (33.3) | |
| Critical | 6 (2.1) | 0 (0.0) | 6 (66.7) | |
| Hospitalization | 48 (16.5) | 41 (14.5) | 7 (77.8) | <0.001 |
| Length of stay in hospital (days), mean±SD (min-max) | 6.4±7.5 (1-35) | 4.0±2.3 (1-10) | 18.9±11.9 (6-35) | <0.001 |
| Mortality | 4 (1.4) | 0 (0.0) | 4 (44.4) | <0.001 |
| Hepatitis (n=256) | ||||
| Absent | 251 (98.0) | 242 (98.0) | 9 (100) | 1.000 |
| HbsAg positive | 5 (2.0) | 5 (2.0) | 0 (0.0) | |
| Chest X-ray | 14 (4.8) | 6 (2.1) | 8 (88.9) | <0.001 |
| Chest X-ray finding (n=13) | 11 (84.6) | 3 (60.0) | 8 (100) | 0.128 |
| CT | 8 (2.7) | 2 (0.7) | 6 (66.7) | <0.001 |
| CT finding (n=8) | 8 (100) | 2 (100) | 6 (100) | - |
| Ritonavir-lopinavir | 2 (0.7) | 0 (0.0) | 2 (22.2) | 0.001 |
| Plaquanil | 0 (0.0) | 282 (100) | 9 (100) | - |
| Favipiravir | 0 (0.0) | 282 (100) | 9 (100) | - |
| Others | 17 (5.8) | 11 (3.9) | 6 (66.7) | <0.001 |
| Systemic steroid | 5 (1.7) | 0 (0.0) | 5 (55.6) | <0.001 |
| Immune plasma | 1 (0.3) | 0 (0.0) | 1 (11.1) | 0.031 |
| IVIG | 2 (0.7) | 0 (0.0) | 2 (22.2) | 0.001 |
| Tocilizumab | 1 (0.3) | 0 (0.0) | 1 (11.1) | 0.031 |
| Values are presented as numbers and precentages (%). ICU: intensive care unit, COVID-19: coronavirus disease 2019, SD: standard deviation, min: minimum, max: maximum, SNVC: Sinovac, BTC: BioNTech, HbsAg: hepatitis B surface antigen, CT: computed tomography, IVIG: intravenous immunoglobulin | ||||